Загрузка...
Coexistent Breast Cancer and Essential Thrombocythemia: How We Addressed the Therapeutic Challenges
Essential thrombocythemia (ET) occurring with breast cancer is uncommon; the therapeutic approach varies and poses a challenge. A 65-year-old female presented to us after being diagnosed with hormone positive, HER2-negative infiltrating ductal carcinoma. She had a platelet count of 600 thou/cu mm. H...
Сохранить в:
| Опубликовано в: : | Case Rep Hematol |
|---|---|
| Главные авторы: | , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Hindawi
2018
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6109582/ https://ncbi.nlm.nih.gov/pubmed/30159181 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/2080185 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|